Profound Medical (Profound Medical) ROE % Adjusted to Book Value : -14.18% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Profound Medical ROE % Adjusted to Book Value?

Profound Medical's ROE % for the quarter that ended in Mar. 2024 was -64.37%. Profound Medical's PB Ratio for the quarter that ended in Mar. 2024 was 4.54. Profound Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -14.18%.

Profound Medical ROE % Adjusted to Book Value Historical Data

The historical data trend for Profound Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical ROE % Adjusted to Book Value Chart

Profound Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-9.94

-9.07

-11.94

-9.89

-11.80

Profound Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-13.28	-10.14	-9.50	-17.56	-14.18

Competitive Comparison of Profound Medical's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Profound Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Profound Medical's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Profound Medical's ROE % Adjusted to Book Value falls into.

Profound Medical ROE % Adjusted to Book Value Calculation

Profound Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-68.69%	/	5.82
	=	-11.80%

Profound Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-64.37%	/	4.54
	=	-14.18%

Profound Medical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Profound Medical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Profound Medical (Profound Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (NAS:PROF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PRN:Canada

Address

2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.